2023
Outcomes after ischemic stroke for dual-eligible Medicare-Medicaid beneficiaries in the United States
Leifheit E, Wang Y, Goldstein L, Lichtman J. Outcomes after ischemic stroke for dual-eligible Medicare-Medicaid beneficiaries in the United States. PLOS ONE 2023, 18: e0292546. PMID: 37797070, PMCID: PMC10553827, DOI: 10.1371/journal.pone.0292546.Peer-Reviewed Original ResearchConceptsStroke hospitalization ratesMedicare beneficiariesIschemic strokeHospitalization ratesUS acute care hospitalsDual-eligible patientsLong-term mortalityUS Medicare beneficiariesIschemic stroke hospitalizationsPost-stroke outcomesAcute care hospitalsService Medicare beneficiariesDual-eligible statusDual-eligible beneficiariesPercentage of beneficiariesCause readmissionHigher readmissionClinical factorsDual eligibilityAdjusted analysisPoor outcomeStroke patientsCox regressionStroke hospitalizationsPrincipal diagnosisAssociation of short-term hospital-level outcome metrics with 1-year mortality and recurrence for US Medicare beneficiaries with ischemic stroke
Wang Y, Leifheit E, Goldstein L, Lichtman J. Association of short-term hospital-level outcome metrics with 1-year mortality and recurrence for US Medicare beneficiaries with ischemic stroke. PLOS ONE 2023, 18: e0289790. PMID: 37561680, PMCID: PMC10414659, DOI: 10.1371/journal.pone.0289790.Peer-Reviewed Original ResearchConceptsIschemic strokeInverse probability weightsStroke patientsCause mortalityOutcome metricsLower riskUS hospitalsBetter long-term outcomesRecurrent stroke rateIschemic stroke recurrenceIschemic stroke patientsLong-term outcomesUS Medicare beneficiariesPerformance categoriesIntermediate hospitalsRecurrent strokeStroke recurrenceCohort studyClinical factorsRecurrence ratePrincipal diagnosisPatient riskStroke rateReadmission measuresCox model
2022
Trends in 1-Year Recurrent Ischemic Stroke in the US Medicare Fee-for-Service Population
Leifheit EC, Wang Y, Goldstein LB, Lichtman JH. Trends in 1-Year Recurrent Ischemic Stroke in the US Medicare Fee-for-Service Population. Stroke 2022, 53: 3338-3347. PMID: 36214126, PMCID: PMC11059192, DOI: 10.1161/strokeaha.122.039438.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overCohort StudiesFee-for-Service PlansFemaleHumansIschemic StrokeMaleMedicareStrokeUnited StatesConceptsRecurrent ischemic strokeIschemic strokeRecurrence rateMedicare beneficiariesRecurrent stroke rateSecondary stroke preventionPoor general healthHigh-risk populationHigh recurrence rateService Medicare beneficiariesUS Medicare feeHighest sextileRecurrent strokeStroke preventionStroke recurrenceClinical characteristicsCohort studyGeneral healthPrincipal diagnosisStroke rateUninsured adultsCox modelMedicare feeHigh recurrenceTesting rates
2021
Adherence to Acute Care Measures Affects Mortality in Patients with Ischemic Stroke: The Florida Stroke Registry
Gardener H, Rundek T, Lichtman J, Leifheit E, Wang K, Asdaghi N, Romano JG, Sacco RL. Adherence to Acute Care Measures Affects Mortality in Patients with Ischemic Stroke: The Florida Stroke Registry. Journal Of Stroke And Cerebrovascular Diseases 2021, 30: 105586. PMID: 33412397, PMCID: PMC7880890, DOI: 10.1016/j.jstrokecerebrovasdis.2020.105586.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overFemaleFibrinolytic AgentsFloridaGuideline AdherenceHealthcare DisparitiesHospital MortalityHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIschemic StrokeMaleMedicarePatient ReadmissionPractice Guidelines as TopicPractice Patterns, Physicians'Quality ImprovementQuality Indicators, Health CareRegistriesRisk AssessmentRisk FactorsRisk Reduction BehaviorSmoking CessationThrombolytic TherapyTime FactorsTreatment OutcomeUnited StatesConceptsAcute care measuresFlorida Stroke RegistryHospital readmissionCare measuresStatin therapyRace/ethnicityStroke RegistryAntithrombotic therapyIschemic strokeAntithrombotic useStroke careIntravenous alteplase treatmentMedicare beneficiaries ageAcute stroke careIschemic stroke patientsLong-term mortalityVascular risk factorsRace/ethnic disparitiesFull study populationAlteplase treatmentDVT prophylaxisEligible patientsAnticoagulation therapyCessation counselingStatin use